On Monday, Wave Life Sciences Ltd. (NASDAQ: WVE) opened higher 4.08% from the last session, before settling in for the closing price of $4.66. Price fluctuations for WVE have ranged from $3.15 to $7.67 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 610.91%. Company’s average yearly earnings per share was noted -87.04% at the time writing. With a float of $96.36 million, this company’s outstanding shares have now reached $119.16 million.
Considering the fact that the conglomerate employs 268 people, you should pay attention to its efficiency factor.
Wave Life Sciences Ltd. (WVE) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Wave Life Sciences Ltd. is 21.20%, while institutional ownership is 74.60%. The most recent insider transaction that took place on Apr 03 ’24, was worth 96,421. In this transaction Chief Financial Officer of this company sold 15,630 shares at a rate of $6.17, taking the stock ownership to the 33,921 shares. Before that another transaction happened on Dec 11 ’23, when Company’s Director bought 1,000,000 for $5.00, making the entire transaction worth $5,000,000. This insider now owns 19,202,009 shares in total.
Wave Life Sciences Ltd. (WVE) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -87.04% per share during the next fiscal year.
Wave Life Sciences Ltd. (NASDAQ: WVE) Trading Performance Indicators
Check out the current performance indicators for Wave Life Sciences Ltd. (WVE). In the past quarter, the stock posted a quick ratio of 1.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.55, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -1.07 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd. (WVE)
Compared to the last year’s volume of 0.83 million, its volume of 0.44 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 13.66%. Additionally, its Average True Range was 0.35.
During the past 100 days, Wave Life Sciences Ltd.’s (WVE) raw stochastic average was set at 32.37%, which indicates a significant increase from 14.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.80% in the past 14 days, which was lower than the 100.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.52, while its 200-day Moving Average is $5.06. Nevertheless, the first resistance level for the watch stands at $4.95 in the near term. At $5.06, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.18. If the price goes on to break the first support level at $4.72, it is likely to go to the next support level at $4.60. Now, if the price goes above the second support level, the third support stands at $4.49.
Wave Life Sciences Ltd. (NASDAQ: WVE) Key Stats
There are currently 122,284K shares outstanding in the company with a market cap of 593.06 million. Presently, the company’s annual sales total 113,310 K according to its annual income of -57,510 K. Last quarter, the company’s sales amounted to 29,060 K and its income totaled -16,260 K.
